Analysis of growth in children with ADHD during long-term therapy with once-daily OROS® methylphenidate

被引：0
|
作者：
Lerner, MA
Spencer, T
机构：
[1] Univ Calif Irvine, Irvine, CA 92717 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
PEDIATRIC RESEARCH | 2004年 / 55卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
5
引用
收藏
页码：1A / 1A
页数：1
相关论文
共 50 条
  • [21] Treatment of children with attention-deficit/hyperactivity disorder: Evaluating a switch from conventional methylphenidate to the once-daily OROS formulation of methylphenidate
    Santosh, P
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S451 - S452
  • [22] Evaluation of once-daily OROS methylphenidate in children with attention-deficit/hyperactivity disorder: Effects on sleep, appetite, and tics
    Biederman, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S447 - S448
  • [23] Pooled safety analysis of long-term, once-daily multimatrix mesalazine use
    Da Silva Sanchez, S.
    Wan, H.
    Streck, P.
    Willshire, D.
    Raskin, J. B.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S349 - S349
  • [24] Long-term safety and efficacy of antihypertensive therapy with valsartan 320 mg once-daily
    Asmar, R.
    Mengden, T.
    Brudi, P.
    Kandra, A.
    Di Giovanni, R.
    Parati, G.
    JOURNAL OF HYPERTENSION, 2006, 24 : S19 - S20
  • [25] Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate
    Ginsberg, Ylva
    Hirvikoski, Tatja
    Grann, Martin
    Lindefors, Nils
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2012, 262 (08) : 705 - 724
  • [26] Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate
    Ylva Ginsberg
    Tatja Hirvikoski
    Martin Grann
    Nils Lindefors
    European Archives of Psychiatry and Clinical Neuroscience, 2012, 262 : 705 - 724
  • [27] Effectiveness and safety of the once-daily OROS formulation of methylphenidate in adolescents with attention-deficit/hyperactivity disorder
    Biederman, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S448 - S448
  • [28] Once-daily OROS® methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder
    McGough, James J.
    McBurnett, Keith
    Bukstein, Oscar
    Wilens, Timoth E.
    Greenhill, Laurence
    Lerner, Marc
    Stein, Mark
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (03) : 351 - 356
  • [29] Long-term safety of once-daily multimatrix mesalazine: A pooled clinical trials analysis
    Sanchez, S. D. Silva
    Wan, H.
    Streck, P.
    Willshire, D.
    Raskin, J. B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 106 - 107
  • [30] Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir
    Ananworanich, Jintanat
    Gayet-Ageron, Angele
    Ruxrungtham, Kiat
    Chetchotisakd, Ploenchan
    Prasithsirikul, Wisit
    Kiertiburanakul, Sasisopin
    Munsakul, Warangkana
    Rakasakulkarn, Phitsanu
    Tansuphasawadikul, Somboon
    LeBraz, Michelle
    Jupimai, Thidarat
    Ubolyam, Sasiwimol
    Schutz, Malte
    Hirschel, Bernard
    ANTIVIRAL THERAPY, 2008, 13 (03) : 375 - 380
12345